Stephen Robertson serves as the Executive Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer at Aurinia Pharmaceuticals Inc., a biopharmaceutical company focused on developing and commercializing therapies for autoimmune and inflammatory diseases. In his multifaceted role, Robertson is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team. His leadership has been instrumental in navigating the complex legal landscape of the pharmaceutical industry, helping Aurinia Pharmaceuticals to successfully bring its flagship product, LUPKYNIS, to market for the treatment of lupus nephritis. Prior to joining Aurinia Pharmaceuticals, Robertson amassed a wealth of experience in the legal field, particularly within the life sciences sector. He held senior legal positions at several prominent companies, including Bristol-Myers Squibb, where he served as Vice President and Assistant General Counsel. During his tenure at Bristol-Myers Squibb, Robertson played a key role in managing the company's intellectual property portfolio and handling complex litigation matters. His strategic approach to legal challenges and his ability to foster strong relationships with regulatory bodies have been critical to his success in the industry. Robertson's achievements extend beyond his corporate roles. He is an active member of the legal community, frequently speaking at industry conferences and contributing to discussions on the evolving regulatory environment for pharmaceuticals. His thought leadership has helped shape best practices in compliance and corporate governance. At Aurinia Pharmaceuticals, Robertson continues to drive the company's mission to improve patient outcomes through innovative therapies, leveraging his extensive legal expertise to support the company's growth and development.